Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

500 public trials 86 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Recruiting

Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation

NCT06892223

Conditions: Acute Myeloid Leukaemia, Anemia, Anemia, Refractory, +13 more
Locations: IRCCS Ospedale Policlinico San Martino Genova, GENOVA, Italy

Irccs Istituto Clinico Humanitas Rozzano, MILANO, Italy

View Trial Details

Recruiting

Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients With Aspirin Resistance

NCT06740916

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital Bangkok Noi, Bangkok, Thailand

View Trial Details

Recruiting

Determination of the Clonality Profile in Myeloproliferative Neoplasms and Association With the Thrombotic Complications (CLOJAK)

NCT05839717

Conditions: Bone Marrow Diseases, Cardiovascular Diseases, Embolism and Thrombosis, +6 more
Locations: CHU d'Angers, Service Maladies du Sang Angers, France

CH de Bayonne, Service Hématologie Clinique Bayonne, France

CHU de Bordeaux, Service Médecine Interne et Maladies Infectieuses Bordeaux, France

Institut Bergonié, Service Hématologie Clinique Bordeaux, France

View Trial Details

Recruiting

Children, Adolescents and Young Adults with Myeloproliferative Neoplasia: Study of Clinico-biological Characteristics and Complications (VYP)

NCT06715267

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: CHU de Brest Brest, France

View Trial Details

Recruiting

Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients

NCT04655092

Conditions: Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +7 more
Locations: Ehime University Hospital Toon-shi, Ehime, Japan

Mie University Hospital Tsu, Mie-ken, Japan

Osaka University Hospital Suita-shi, Osaka, Japan

Juntendo University Hospital Bunkyo-ku, Tokyo, Japan

View Trial Details

Recruiting

Myeloproliferative Neoplasms (MPNs) Patient Registry

NCT02760238

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +34 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen

NCT06532084

Conditions: Acute Myeloid Leukemia, in Relapse, Bone Marrow Diseases, Chronic Disease, +15 more
Locations: RM Gorbacheva Research Institute Saint Petersburg, Russia

View Trial Details

Recruiting

BeFluBu vs FluBuRux Conditioning in Haploidentical HCT

NCT06477549

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +19 more
Locations: RM Gorbacheva Research Institute Saint Petersburg, Russia

View Trial Details

Recruiting

Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)

NCT06462664

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Chu Brest Brest, France

View Trial Details

Recruiting

The Patient Cohort of the National Center for Precision Medicine in Leukemia

NCT05326919

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +17 more
Locations: Hôpital Avicenne Bobigny, France

Hopital Robert Debré Paris, France

Hôpital Saint Louis Paris, France

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions